Delivery Order SPE2DR25D2100-SPE2DR26FA0UK
Award Date 12/22/25
Potential Completion Date 12/23/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Belsomra 10 mg tablets (30-count units) valued at $1,705.53 under a firm fixed price contract type. The award, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a competitively awarded, non-set-aside contract. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters and a major hub for pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,119.24 to AmerisourceBergen Drug Corp for Belsomra 15 mg tablets (30-count supply) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,295.84 to AmerisourceBergen Drug Corp for Belsomra 20 mg tablets (30-count) on November 20, 2025, with completion scheduled for November 21, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical products will be delivered...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,070.75 to AmerisourceBergen Drug Corp for the supply of Belsomra 20 mg tablets (30 count) on December 3, 2025, with completion expected by December 4, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded transaction under DLA's broader pharmaceutical procurement framework. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,531.93 to AmerisourceBergen Drug Corp for the supply of Belsomra 20 mg tablets (30-count units) on December 22, 2025, with completion targeted for December 23, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and reflects a routine pharmaceutical procurement under the agency's medical supply chain operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Belsomra 5 mg tablets (30-count) valued at $1,079.02. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 7, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's demonstrated capability to compete...
- The Defense Logistics Agency awarded a delivery order valued at $1,421.68 to AmerisourceBergen Drug Corp for the supply of Belsomra 15 mg tablets (30-count packages). This non-set-aside, competitively awarded contract employs firm fixed pricing and is scheduled for ultimate completion on December 18, 2025. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical support vehicle running through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,069.68 to AmerisourceBergen Drug Corp for 30 tablets of Belsomra 10 mg on July 30, 2025. This non-set-aside contract employs firm fixed pricing and is classified as a delivery order, with an ultimate completion date of July 31, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The award represents a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,219.25 by the Defense Logistics Agency on December 18, 2025, for the supply of Belsomra 20 mg tablets (30-count packaging). This firm fixed-price, non-competitive set-aside contract is scheduled for completion by December 19, 2025, with performance occurring at the vendor's Conshohocken facility. The award represents a child contract under...
- The Defense Logistics Agency awarded a $1,185.57 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Belsomra 20 mg, a pharmaceutical product for treating insomnia. This competitively awarded, firm fixed-price contract was issued on September 11, 2025, with an ultimate completion date of September 12, 2025, and involves performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery...